Insights

News Show all

News

Berchtesgaden Microbiome Science Days 2022

Microbiome Summit Meeting in the Alps

Once again, with the strong participation of the IKMB, the 6th annual symposium Berchtesgaden Microbiome Science Days (BMSD) took place.

The role of the microbiome in complex chronic diseasesread more

Events Show all

25
Sep

DDA PostDoc Summit 2022

Green Solution House, Strandvejen 79, 3700 Rønne, Bornholm, Denmark
08
Oct

UEG Week 2022

Messe Wien Exhibition and Congress Center & Online

Our mission

Patterns of gut microbiome dysbiosis in patients with inflammatory bowel diseases are inconsistent among published studies, probably owing to the heterogeneity of the disease and given the fact that patients enrolled in research studies are often treated and in remission. Therefore, more microbiome studies in “early” (incident) patients that are treatment-naïve and in high-risk individuals are needed. In addition, the microbiome field has to move from association to rather mechanistic studies in order to understand the actual functions and to also prove the associations that serve as hypotheses.

Institute of Clinical Molecular Biology
Kiel University
Rosalind-Franklin-Str. 12
24105 Kiel

Spokesperson
Prof. Dr. rer. nat. Andre Franke
Fon: +49(0)431-500-15112
a.franke@ikmb-uni-kiel.de

Coordination
Annika Gröning
Fon: +49 (0)431 500-15115
a.groening@ikmb.uni-kiel.de

Doctoral qualification programme
Eike Zell
Fon: +49 (0)431 500-15113
e.zell@ikmb.uni-kiel.de

Participating Institutes